AI and Autonomy Big tech is turning to nuclear power to fuel its generative-AI ambitions Data centers consume vast amounts of electricity to train and run these models Joseph MortonOctober 30, 2024
Medical and Pharmaceutical MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline Rowan DunneOctober 30, 2024
Medical and Pharmaceutical Ireland launches largest lung cancer research program to date This €4.9-million-euro initiative is being funded by the Irish Cancer Society Rowan DunneOctober 30, 2024
AI and Autonomy Innovative Eyewear surges on release of ‘Lucyd Armor’ smart safety specs These industrial-use glasses have a walkie talkie feature and auto-tinting lenses, among other things Rowan DunneOctober 29, 2024
Alternative Energy Lightbridge Corporation shares jump 35% on positive strong financial performance The company has also drawn increased interest from major tech companies like Google and Amazon Web Services Joseph MortonOctober 29, 2024
Gold U.S. recycles most gold from scrap electronics by far, report shows China is number 2, but it doesn't even recycle half as much Rowan DunneOctober 29, 2024
Crypto/Blockchain Coinbase introduces artificial intelligence into crypto wallets The introduction of Based Agent reflects a growing trend in the integration of AI within the blockchain sector Joseph MortonOctober 28, 2024
Medical and Pharmaceutical South Korea’s Yuhan has 690% profit spike on U.S. lung cancer drug sales Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August Rowan DunneOctober 28, 2024
Gold Calibre Mining highlights responsible energy usage in first-ever Climate Report The gold producer aims to incorporate climate risk factors into daily operational decision-making Rowan DunneOctober 28, 2024
Medical and Pharmaceutical Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results Analysts at Cantor Fitzgerald and JP Morgan Chase & Co recently gave the company an overweight rating Rowan DunneOctober 25, 2024